CHGPM receives funding from the UW2020 award.
The goal of the UW2020 is to help fund groundbreaking research at the University of Wisconsin – Madison. Those projects that are awarded the UW2020 have the potential to transform a field of study. CHGPM’s Stephen Meyn in partnership with the UW Biotechnology Center’s Chris Bradford and Joshua Hyman was awarded this year’s grant to get the de novo human genome assembly project up and running. See the whole story here
Precision Genomic Medicine
A new clinical paradigm in which knowledge gained from analyzing the informational content of an individual’s genome is used to guide health care decisions throughout life, in order to anticipate, diagnose, and manage disease.
Because we are at the beginning of the era of precision genomic medicine, there is much to be learned before the full potential of this new discipline can be realized. Critical knowledge gaps in fundamental science, clinical practice, and health policy must be addressed and implementation initiatives developed that maximize benefits and minimize harms.
To address these issues, transform clinical care, and improve health outcomes, The Center for Human Genomics and Precision Medicine is developing a comprehensive strategy to catalyze basic science discovery in human genomics and related fields, accelerate innovative translation of research results into cutting-edge clinical applications, and democratize delivery of genome-based clinical services.